Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (Q3)Dec 31, 2025 | (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -9.82%3.48M | 17.49%3.65M | 11.15%3.55M | 3.81%13.3M | -2.63%3.15M | 14.32%3.86M | 2.89%3.1M | 0.08%3.19M | 13.82%12.81M | 6.82%3.23M |
| Operating revenue | -9.82%3.48M | 17.49%3.65M | 11.15%3.55M | 3.81%13.3M | -2.63%3.15M | 14.32%3.86M | 2.89%3.1M | 0.08%3.19M | 13.82%12.81M | 6.82%3.23M |
| Cost of revenue | -9.64%2.61M | 16.70%2.74M | 7.52%2.59M | 0.45%9.93M | -9.37%2.28M | 12.29%2.89M | -0.11%2.35M | -1.37%2.41M | 22.53%9.89M | 10.61%2.52M |
| Gross profit | -10.36%864.93K | 19.94%905.03K | 22.29%958.23K | 15.14%3.37M | 21.05%866.17K | 20.85%964.91K | 13.53%754.55K | 4.81%783.59K | -8.23%2.93M | -4.65%715.56K |
| Operating expense | 10.38%1.07M | -3.55%991.45K | 3.48%1.16M | -13.10%4.17M | -13.32%1.03M | -22.16%965.1K | -12.77%1.03M | -2.88%1.12M | -3.43%4.8M | -15.26%1.19M |
| Selling and administrative expenses | 11.07%1.03M | -1.65%978.88K | 4.54%1.11M | -12.13%3.98M | -14.05%981.09K | -21.02%923.89K | -10.18%995.3K | -1.59%1.06M | -2.79%4.53M | -5.16%1.14M |
| -Selling and marketing expense | 40.69%159.66K | -3.57%132.84K | -2.35%125.45K | 1.25%495.24K | 41.92%86.57K | -12.89%113.48K | 1.92%137.77K | -6.79%128.47K | -33.74%489.12K | -53.87%61K |
| -General and administrative expense | 6.92%866.48K | -1.34%846.03K | 5.49%987.38K | -13.75%3.48M | -17.21%894.52K | -22.04%810.41K | -11.86%857.53K | -0.84%936.04K | 3.04%4.04M | 0.85%1.08M |
| Depreciation amortization depletion | -4.88%37.78K | -5.99%36.65K | -0.08%39K | -29.51%158.04K | 4.98%40.31K | -35.57%39.72K | -36.04%38.99K | -38.24%39.03K | -12.94%224.19K | -39.69%38.39K |
| -Depreciation and amortization | -4.88%37.78K | -5.99%36.65K | -0.08%39K | -29.51%158.04K | 4.98%40.31K | -35.57%39.72K | -36.04%38.99K | -38.24%39.03K | -12.94%224.19K | -39.69%38.39K |
| Other operating expenses | -8.60%1.36K | -282.17%-24.08K | -44.83%11.34K | -27.12%36.26K | -2.90%12.87K | -82.42%1.49K | -166.68%-6.3K | 64.83%20.55K | -12.50%49.75K | -90.57%13.26K |
| Operating profit | -102,117.86%-200.35K | 68.39%-86.42K | 39.81%-204.94K | 57.19%-802.14K | 64.80%-168.1K | 99.96%-196 | 46.79%-273.44K | 16.91%-340.49K | -5.17%-1.87M | 27.36%-477.6K |
| Net non-operating interest income (expenses) | -80.62%4.76K | -69.45%8.19K | -51.60%14.88K | -29.82%101.97K | -43.12%19.84K | -37.92%24.58K | -26.67%26.8K | -10.28%30.75K | 64.82%145.3K | 9.27%34.88K |
| Non-operating interest income | -72.07%7.21K | -59.79%11.43K | -53.69%15.18K | -31.10%107.66K | -44.64%20.65K | -39.57%25.81K | -30.08%28.42K | -7.91%32.79K | 59.26%156.26K | 9.50%37.3K |
| Non-operating interest expense | 99.27%2.45K | 100.74%3.24K | -85.10%304 | -48.05%5.7K | -66.42%813 | -60.59%1.23K | -60.56%1.61K | 52.92%2.04K | 10.05%10.96K | 12.92%2.42K |
| Other net income (expenses) | -74.62%23.43K | -4.68%20.94K | 163.60%4.83K | -605.61%-325.71K | -2,935.65%-452.31K | 439.55%92.33K | -25.55%21.97K | 73.91%-7.6K | -66.92%64.42K | -89.29%15.95K |
| Gain on sale of security | -199.48%-18.26K | 160.75%5.09K | 72.82%-4.11K | -41.32%-83.09K | -2,731.29%-77.97K | 208.65%18.36K | -290.56%-8.38K | 69.33%-15.11K | 14.13%-58.79K | 126.03%2.96K |
| Special income (charges) | ---- | ---- | ---- | -3,849.21%-395K | ---- | ---- | ---- | ---- | ---10K | ---- |
| -Less:Impairment of capital assets | ---- | ---- | ---- | 3,849.21%395K | ---- | ---- | ---- | ---- | --10K | ---- |
| Other non-operating income (expenses) | -43.63%41.69K | -47.76%15.85K | 19.06%8.94K | 14.39%152.38K | -10.17%20.65K | 117.50%73.97K | 20.83%30.35K | -62.71%7.51K | -49.39%133.21K | -85.66%22.99K |
| Income before tax | -247.50%-172.15K | 74.50%-57.3K | 41.63%-185.23K | 38.35%-1.03M | -40.73%-600.58K | 130.33%116.72K | 49.83%-224.67K | 21.58%-317.34K | -11.03%-1.66M | 10.46%-426.77K |
| Income tax | 0 | -130.85%-14.35K | -31.05%32.07K | -46.42K | -62.77%46.51K | 46.51K | ||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -205.53%-172.15K | 74.50%-57.3K | 41.63%-185.23K | 40.87%-1.01M | -33.67%-632.65K | 142.40%163.13K | 49.83%-224.67K | 21.58%-317.34K | -5.35%-1.71M | 21.32%-473.29K |
| Net income continuous operations | -205.53%-172.15K | 74.50%-57.3K | 41.63%-185.23K | 40.87%-1.01M | -33.67%-632.65K | 142.40%163.13K | 49.83%-224.67K | 21.58%-317.34K | -5.35%-1.71M | 21.32%-473.29K |
| Noncontrolling interests | -68.78%18.2K | 179.97%28.51K | 277.71%45.71K | -5,878.78%-20.57K | -2,538.34%-55.33K | 331.86%58.31K | -1,740.42%-35.65K | 223.35%12.1K | -100.55%-344 | 82.09%-2.1K |
| Net income attributable to the company | -281.59%-190.36K | 54.61%-85.8K | 29.90%-230.94K | 42.06%-990.96K | -22.52%-577.32K | 126.32%104.83K | 57.61%-189.02K | 16.56%-329.45K | -1.41%-1.71M | 20.12%-471.19K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -281.59%-190.36K | 54.61%-85.8K | 29.90%-230.94K | 42.06%-990.96K | -22.52%-577.32K | 126.32%104.83K | 57.61%-189.02K | 16.56%-329.45K | -1.41%-1.71M | 20.12%-471.19K |
| Diluted earnings per share | 0 | 0 | 0 | 50.00%-0.01 | 0.00%-0.01 | 0 | 58.61%-0.0016 | 0 | 0.00%-0.02 | 0.00%-0.01 |
| Basic earnings per share | 0 | 0 | 0 | 50.00%-0.01 | 0.00%-0.01 | 0 | 58.61%-0.0016 | 0 | 0.00%-0.02 | 0.00%-0.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.